Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging.

Rodríguez-Agustín, Andrea; Casanova, Víctor; Grau-Expósito, Judith; Sánchez-Palomino, Sonsoles; Alcamí, José; Climent, Núria

Rodríguez-Agustín, Andrea; Casanova, Víctor; Grau-Expósito, Judith; Sánchez-Palomino, Sonsoles; Alcamí, José; Climent, Núria.

Afiliación

Rodríguez-Agustín A; HIV Unit, Hospital Clínic-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
Casanova V; HIV Unit, Hospital Clínic-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
Grau-Expósito J; HIV Unit, Hospital Clínic-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
Sánchez-Palomino S; HIV Unit, Hospital Clínic-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
Alcamí J; CIBER of Infectious Diseases (CIBERINFEC), 28029 Madrid, Spain.
Climent N; CIBER of Infectious Diseases (CIBERINFEC), 28029 Madrid, Spain.

Pharmaceutics ; 15(3)2023 Mar 11.

Article en En | MEDLINE | ID: mdl-36986778

Palabras clave

CML; CMV; HIV functional cure; HIV-1; anti-aging; cancer; dasatinib; memory-like NK cells; senolytic; tyrosine kinase inhibitors; Î³Î´ T cells

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google